Effects of KMT2D mutation and its exon 39 mutation on the immune microenvironment and drug sensitivity in colorectal adenocarcinoma.

Liu, Chuan; Jin, Yuzhi; Zhang, Hangyu; Yan, Junrong; Guo, Yixuan; Bao, Xuanwen; Zhao, Peng

Liu, Chuan; Jin, Yuzhi; Zhang, Hangyu; Yan, Junrong; Guo, Yixuan; Bao, Xuanwen; Zhao, Peng.

Afiliación

Liu C; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.
Jin Y; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.
Zhang H; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.
Yan J; Medical Department, Nanjing Geneseeq Technology Inc., Nanjing 210032, Jiangsu Province, People's Republic of China.
Guo Y; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.
Bao X; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.
Zhao P; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, People's Republic of China.

Heliyon ; 9(2): e13629, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36846668

Palabras clave

Colorectal adenocarcinoma; Drug sensitivity; Exon 39; Immune microenvironment; KMT2D; Mutation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google